Effects of MD-7246 on Irritable Bowel Syndrome With Diarrhea Effects of MD-7246 on Irritable Bowel Syndrome With Diarrhea

This study evaluated the efficacy, safety and dose-response of MD-7246, a delayed-release formulation of linaclotide, in patients with IBS-D.Alimentary Pharmacology & Therapeutics
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news